Joan Albert Barberà Mir-rekin lankidetzan egindako argitalpenak (14)

2023

  1. Predictors of the response to phosphodiesterase-5 inhibitors in pulmonary arterial hypertension: an analysis of the Spanish registry

    Respiratory Research, Vol. 24, Núm. 1

2022

  1. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension

    Journal of Heart and Lung Transplantation, Vol. 41, Núm. 6, pp. 716-721

2021

  1. Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry

    Internal Medicine Journal, Vol. 51, Núm. 3, pp. 355-365

  2. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 178

2020

  1. Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: Results from the PRACMA study

    BMC Pulmonary Medicine, Vol. 20, Núm. 1

  2. Total, bioavailable, and free vitamin D levels and their prognostic value in pulmonary arterial hypertension

    Journal of Clinical Medicine, Vol. 9, Núm. 2

2016

  1. Management and outcomes in chronic thromboembolic pulmonary hypertension: From expert centers to a nationwide perspective

    International Journal of Cardiology, Vol. 203, pp. 938-944

2015

  1. The distribution of the obstruction in the pulmonary arteries modifies pulsatile right ventricular afterload in pulmonary hypertension

    International Journal of Cardiology, Vol. 181, pp. 232-234

2013

  1. Health-Related Quality of Life in a National Cohort of Patients With Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension

    Archivos de Bronconeumologia, Vol. 49, Núm. 5, pp. 181-188

2012

  1. Cost effectiveness of prostacyclins in pulmonary arterial hypertension

    Applied Health Economics and Health Policy, Vol. 10, Núm. 3, pp. 175-188

  2. Survival in pulmonary hypertension in Spain: Insights from the Spanish registry

    European Respiratory Journal, Vol. 40, Núm. 3, pp. 596-603

2010

  1. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension

    Liver Transplantation, Vol. 16, Núm. 3, pp. 348-356

2008

  1. Standards of care in pulmonary hypertension

    Revista Espanola de Cardiologia, Vol. 61, Núm. 2, pp. 170-184

  2. Standards of care in pulmonary hypertension. Consensus statement of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Cardiology (SEC)

    Archivos de Bronconeumologia, Vol. 44, Núm. 2, pp. 87-99